In contrast, in glioma, loss of PTEN has been reported as a critical event that leads to Notch inhibitor resistance by transferring the “oncogene addiction” from the Notch to the PI3K/AKT pathway [198], supporting the regulatory link between Notch and the PTEN/PI3K/AKT pathway. The gene discussed is PTEN; the disease is glioma.